
|Articles|September 16, 2002
Are antirejection drugs on the endangered list?
Transplant patients may one day be completely free from grueling regimens of immunosuppressive drugs, according to researchers from India, Stanford University, and the University of Pittsburgh. The investigators presented findings from three studies at the recent 19th International Congress of The Transplantation Society, which was held in Miami, Fla.
Advertisement
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Drug Topics
1
Embedded Pharmacists Are Vital Yet Underutilized in Diabetes Care
2
Executive Order Calls for Realignment of Childhood Vaccines
3
The Prodigious PBM Pivot: How Supply Chain Entities Will Move Forward After CAA 2026
4
Q&A: Pharmacists Can Address ADA Standards Across All Settings
5





























































